Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Concerns sort of short term sort of not

<< Previous

Bullboard Posts

Next >>

Comment by Ogre03on Dec 02, 2020 12:36pm

129 Views

Post# 32018532

RE:RE:Concerns sort of short term sort of not

Sorry bud but alas when you take off the mask I don't look a damn thing like this dumpster fellow. Yup new account first account only account. Been holding since 2018. Got sorta burned in weed stocks (should of sold before legalization) got in early enough it didn't hurt anything but my dreams. I'm vested in anitbe heading for a knee replacement in my old age and running anti inflammatories for the last 5 years pretty steady. I want / need this to work and come to market. I just don't want to get bushwacked in the process.

<< Previous

Bullboard Posts

Next >>

Ivanhoe Mines initiates Phase 3 concentrator construction